Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting - Fortress Biotech (NASDAQ:FBIO), Avenue Therapeutics (NASDAQ:ATXI)

MIAMI, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of therapies for the

Related Keywords

Miami ,Florida ,United States ,Orlando ,American ,Baergic Bio ,Alexandra Maclean ,Jaclyn Jaffe ,Amy Chappell ,Astrazeneca ,Avenue Therapeutics Inc ,American Epilepsy Society ,Fortress Biotech Inc ,Genetic Absence Epilepsy Rat ,Receptors Potently ,Fully Blocks Seizures ,Genetic Absence ,Chief Executive Officer ,Fortress Biotech ,Private Securities Litigation Reform Act ,